Who is eligible for clinical trial NCT06932302?

Participants must meet protocol criteria for Female Sexual Dysfunction. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06932302 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2025-12-16

At-Home Neuromodulation for Female Sexual Dysfunction (NCT06932302)

🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: University of Michigan

🩺 Plain-English Summary (8th-Grade Level)

This pilot study investigates the regular use of non-invasive dorsal genital nerve stimulation (DGS) for the treatment of female sexual dysfunction (FSD). The researchers aim to determine whether subjects with FSD can correctly follow an at-home treatment regimen and to demonstrate that DGS can improve FSD arousal symptoms in premenopausal and postmenopausal women. Some subjects will use a smart vibrator for comparison to DGS.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (10 items).

Location: University of Michigan — Ann Arbor, Michigan

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Capable of speaking and understanding English.
Able to comprehend the clinical study procedures and provide informed consent.
Identified as having female sexual dysfunction with a Female Sexual Function Index (FSFI) score of 26.55 or less and a score of 3 or less on one or more of the FSFI subdomains of lubrication, arousal, and orgasm.
Willing and able to adhere to the study protocol
Able to attend experimental sessions at Michigan Medicine at both the start and conclusion of the study.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Not currently sexually active.
Pregnant or planning to get pregnant during the study period.
History of a neurological disorder or impairments affecting pelvic organ function, including diagnosed with dorsal genital nerve damage, lower motor dysfunction, or other related conditions.
Implanted with a neurostimulator for bladder or bowel function.
Have a skin condition that would predispose them to sensitivity to the stimulation electrodes.
Female sexual dysfunction limited solely to low desire, without issues in lubrication, arousal, or orgasm.
Clinically diagnosed bladder dysfunction, pelvic pain, or other pelvic organ symptoms; or a score of 8 or higher on the American Urological Association Symptom Index (AUASI).
Unable or unwilling to adhere to the study protocol
Simultaneously participating in another research study that may affect the results of this study.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

University of Michigan — Ann Arbor, Michigan

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗